HIG BioVentures closes USD268m Life Sciences Fund
HIG Capital has successfully closed HIG BioVentures II, LP, which was over-subscribed with total aggregate commitments of USD268 million, exceeding its USD250 million target. The funds were raised entirely from limited partners specific to HIG BioVentures II, including a diverse group of top-tier global investors, including public and private pension
